Identifying factors associated with prostate cancer progression and survival in african american men: the respond cohort - african american (AA) men have a >80% higher incidence and are more than…

Active Cooperative Agreement Awarded Last action

Award ID
U01CA287036
Recipient
Awarding agency
Obligated
$4,092,804

Award facts

Assistance listing
93.393 Cancer Cause and Prevention Research
Completion date 47% complete
Place of performance
Los Angeles, CA 90033, USA

Award details come from USAspending.gov.

Description

Identifying factors associated with prostate cancer progression and survival in african american men: the respond cohort - african american (AA) men have a >80% higher incidence and are more than twice as likely to DIE from prostate cancer (PCA) than white men. The reasons for the high burden relating to poor outcomes of PCA among AA men are largely unknown. Respond is a nation-wide and comprehensive effort to understand PCA health disparities, with research focused on the role of stress and the contextual environment, access to care and treatment, inherited susceptibility, tumor somatic genetics, the inflammatory tumor microenvironment, as well as the integration of these factors in the diagnosis of aggressive disease. AA men, diagnosed with PCA between 2015 and 2020, have been sampled and recruited from cancer registries in 7 states (california, georgia, louisiana, michigan (detroit metropolitan area), new jersey, texas, and new york). By december of 2023, the cohort will include >12,700 AA men with PCA who completed a baseline survey, >7,600 who provided saliva/germline DNA and tumor samples obtained for >3,400. Over the next 5 years, we will leverage the respond recruitment infrastructure and research expertise to update comorbidities, lifestyle behaviors, experience of stress, access to care, and neighborhood environmental data, as well as to obtain information on PCA oncologic outcomes including disease progression/recurrence (P/R) and mortality. Long-term follow-up of this cohort is essential since the development of progressive disease may take several years after diagnosis. These data will be used to address a number of scientific questions and hypotheses aimed at understanding key social and biological factors and their inter-relationships that contribute to disease P/R and survival in this high-risk population. In aim 1, we will examine multi-level provider, geospatial and personal factors that define access to care and their relationship to PCA, P/R and survival as well as patient-reported outcomes. In aim 2, we will investigate residence in persistently disinvested neighborhoods and modification by chronic exposure to life-course structural and social stressors on PCA aggressiveness, P/R and survival. In aim 3, we will evaluate the impact of lifestyle factors, comorbid conditions and genetic risk factors on PCA P/R and mortality. Lastly, in aim 4, we will leverage deep learning approaches applied to histopathologic images to improve prediction of PCA P/R and survival in AA men. Each aim addresses a distinct research domain (access to care, social environment/stress, lifestyle and genetic factors and tumor features), yet, when studied together in a single cohort, scientific synergy is gained and a far more comprehensive picture of the major factors that contribute to PCA P/R and PCA survival in AA men. We expect these findings to have broad reaching significance and address numerous challenges in the clinical management and prevention of P/R in AA men, and ultimately improve health outcomes. Furthermore, we expect respond to become an invaluable resource for advancing our understanding of the intersecting multilevel factors contributing to the longstanding high burden of PCA among AA men.

Transactions

Action Obligated Date
Amendment $1,068,065
Amendment $1,404,536
Original award $1,620,203

Subawards

Subrecipient Amount Awarded
The Regents Of The University Of Colorado Identifying factors associated with prostate cancer progression and survival in African American men: The RESPOND Cohort $11,968
Rutgers The State University Of New Jersey $155,431
The Johns Hopkins University $366,547
The Regents Of The University Of California. San Francisco $237,266
Public Health Institute $112,479
Louisiana State University Health Sciences Center New Orleans $200,039
Baylor College Of Medicine $141,019
Health Research, Inc. $157,117
Wayne State University $141,963
Emory University $256,479

Quick answers

Who received award U01CA287036?

U01CA287036 was awarded to University Of Southern California by National Cancer Institute (National Institutes of Health) on July 23, 2024.

How much is award U01CA287036 worth?

$4,092,804 has been obligated on U01CA287036.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award